REZOLVE AI PLC (RZLV)
Rezolve Ai Board Moves to Authorize Capital Reduction and Up to $300 Million Share Repurchase Program
Rezolve Ai Board Moves to Authorize Capital Reduction and Up to $300 Million Share Repurchase Program
Kalaris to Present at Clinical Trials at the Summit 2026
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
BrightSpring Health Services, Inc. Welcomes Dr. Nigam H. Shah to Board of Directors
Cushman & Wakefield Advises Ericsson On Record 1 Million-Square-Foot HQ Transaction
UniFirst Shareholders Approve Transaction with Cintas
Independent Bank Corporation Announces Regulatory Approvals to Acquire HCB Financial Corp. and Highpoint Community Bank
CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia
Everlert, Inc. (OTC: EVLI), Announces Discussions Regards Potential Acquisition of the Rimrock Copper-Gold Project in Nevada
Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress